• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD face a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these medications can affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological conditions like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the benefits of taking them against potential risks to the fetus. Doctors don't have enough data to make unambiguous recommendations however they can adhd medication help with memory provide information on the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during early pregnancy did not face a significantly increased risk of fetal heart malformations or major birth defects that are structural. The researchers used a large population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy, as well as those who had not. Clinical geneticists and pediatric cardiologists looked over the cases to ensure an accurate case classification and to minimize the chance of bias.

However, the study had its limitations. Most important, they were unable to distinguish the effects of the medication from the disorder that is underlying. This limitation makes it difficult for researchers to determine whether the few associations observed between the groups that were exposed to the use of medication or confounded by co-morbidities. Additionally, the researchers did not look at long-term offspring outcomes.

The study found that infants whose mothers had taken ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to mothers who didn't take any medication during pregnancy or had stopped taking their medication before or during pregnancy. This was due to central nervous system disorders, and the higher risk of admission did not appear to be affected by the type of stimulant medications were used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean birth or having a baby born with an low Apgar score (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during early pregnancy could be offset by the greater benefit to both mother and child of continued treatment for the woman's condition. Physicians should talk to their patients about this and try to help them develop coping strategies that could reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. These decisions are frequently made without clear and authoritative evidence. Instead, doctors have to take into account their own experience, the experience of other doctors and the research that has been conducted on the subject.

Particularly, the issue of possible risks to the infant can be difficult. Many studies on this subject are based on observational data instead of controlled research and their findings are often contradictory. Furthermore, most studies restrict their analysis to live births, which may underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study presented in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion is that while some studies have shown an association between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies have a neutral or slightly negative impact. In all cases, a careful study of the benefits and risks is required.

For many women with ADHD and ADD, the decision to discontinue medication is difficult, if not impossible. In fact, in an article recently published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for patients with ADHD. Furthermore, a loss of medication may affect the ability to do job-related tasks and drive safely, which are important aspects of daily life for a lot of people with ADHD.

She suggests that women who are not sure whether to take the medication or discontinue it due to pregnancy educate family members, colleagues, and acquaintances about the condition, its impact on daily functioning and the benefits of keeping the current treatment plan. It can also help the woman feel supported as she struggles with her decision. It is important to note that some medications can pass through the placenta, so if the patient decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug could be passed on to the baby.

Birth Defects Risk

As the use and abuse of best adhd medication for adults with anxiety drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD), increases the concern over the potential effects of these drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this topic. Utilizing two huge data sets, researchers were able to look at more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Although the risk overall is low, the researchers discovered that the first-trimester exposure to ADHD medications was linked to an increased risk of specific heart defects, such as ventriculo-septal defect (VSD).

The researchers behind the study found no association between early medication use and other congenital abnormalities, like facial clefting, or club foot. The findings are in line with previous studies revealing an increase, but not significant, in the risk of heart malformations in women who started taking adhd medication how does it work medications before the birth of their child. The risk grew in the latter half of pregnancy, when a lot of women begin to discontinue their best adhd medication for adults with anxiety medication.

Women who were taking ADHD medication during the first trimester were more likely to require a caesarean delivery, have an insufficient Apgar after delivery and have a baby that needed help breathing at birth. The authors of the study were unable to eliminate selection bias because they restricted the study to women without other medical conditions that could have contributed to the findings.

The researchers hope their study will serve to inform the clinical decisions of doctors who encounter pregnant women. The researchers advise that, while discussing the risks and benefits are important, the decision regarding whether or not to stop taking medication should be in light of the severity of each woman's ADHD symptoms and her needs.

The authors caution that, although stopping the medication is a possibility to consider, it is not recommended due to the high prevalence of depression and mental health issues for women who are pregnant or who have recently given birth. Additionally, the research suggests that women who choose to stop taking their medications are more likely to have difficulties adjusting to life without them following the baby's arrival.

Nursing

It can be overwhelming to become a mom. Women with ADHD who have to manage their symptoms while attending doctor appointments as well as getting ready for the arrival of their child and adjusting to new household routines are often faced with a number of difficulties. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in low amounts, so the risk for infant who is breastfeeding is low. However, the frequency of exposure to medication by the infant can differ based on the dosage, frequency it is administered and the time of the day the medication is administered. In addition, different medications are introduced into the baby's system via the gastrointestinal tract or breast milk. The impact of these medications on the health of a newborn is not fully known.

Because of the lack of evidence, some doctors may be inclined to discontinue stimulant medication during a woman's pregnancy. It's a difficult choice for the woman, who must weigh the benefits of continuing her medication against the risks to the fetus. Until more information becomes available, GPs can inquire about pregnant patients if they have a background of ADHD or if they plan to take medication during the perinatal period.

A growing number of studies have shown that the majority of women are able to safely continue their ADHD medication during pregnancy and breastfeeding. As a result, more and more patients are choosing to do so and, in consultation with their doctor they have found that the benefits of continuing their current medication far outweigh any potential risks.

It is essential for women with ADHD who are considering breastfeeding to seek out a specialist psychiatrist's advice prior to becoming pregnant. They should review their medications with their physician and discuss the pros and cons of continued treatment, including non-pharmacological management strategies. Psychoeducation should also be provided to help pregnant women suffering from ADHD recognize their symptoms and the root cause, learn about available treatment options and reinforce existing coping strategies. This should be a multidisciplinary approach with the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include the discussion of a treatment plan for both mother and child, and monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.